Vaccine Market To Hit $19.2B by 2010

[Guest guest]

Thursday, July 26, 2007

Vaccine Market To Hit $19.2B by 2010

" United States represents the largest market for human vaccines with

sales estimated at US$6.9 billion for 2007. Within Europe, France,

Germany, and United Kingdom together account for more than 3/4th of

the market. In Japan, Pediatric prophylactic vaccines sales are

likely to grow at a compounded annual rate of 9.9% over the period

2005-2010. Human vaccines market in Asia-Pacific is projected to

reach US$1.3 billion by the year 2010. Most multinational companies

engaged in vaccine production are based in the US and

Europe.....Pediatric combination vaccines, another new entrant in the

vaccines market are forecast to fuel growth in the coming years. The

market is expected to witness new levels with adoption of novel

vaccine delivery mechanisms such as edible, oral, and mucosal. Also

critical to market success is the need for using improved adjuvants

in vaccines for optimal immunogenicity.....Dominant players in the

market comprise leading pharmaceutical companies including

Sanofi-Aventis, GlaxoKline, Wyeth, and Merck. These companies

together command about 80% share of the global human vaccines

market. " - Global Industry Analysts, Inc.

Barbara Loe Fisher Commentary:

If anyone doubts why drug companies making and selling vaccines are

lobbying so hard to convince California legislators to pass a

precedent-setting law that would automatically mandate every new

vaccine the CDC recommends for " universal use " by all children, the

recent market analysis by Global Industry Analysts gives the answer:

forcing vaccine use is a multi-billion dollar business. The U.S. is

the largest market for human vaccines: vaccine manufacturers will

rake in $6.9B in 2007. Much of the profit is guaranteed because the

lobbying alliance between drug companies, public health officials and

pediatricians that has formed during the past quarter century has

worked hard to convince politicians to mandate the use of more

vaccines by US citizens than are used by any other country in the world.

The freedom to exercise informed consent to vaccination and make

informed voluntary vaccine choices in the US is being eroded by

clueless legislators listening to profit-seeking drug companies and

zealous government health officials in search of a 100 percent

vaccination rate. No question that forced use of multiple vaccines

makes for good profits. But where is the science that demonstrates it

leads to good health?

The worldwide human vaccines market is projected to reach $19.2B and

it is no surprise that " therapeutic " vaccines are projected to be the

fastest growing segment with $3.3B projected sales by 2010 in the

U.S. alone. The therapeutic vaccine market includes people suffering

with chronic brain and immune system dysfunction, the very kinds of

chronic diseases and disorders that can be caused by prophylactic

vaccine use. In other words, those children who are harmed by forced

prophylactic vaccine use will become consumers of therapeutic vaccines.

The price we will pay for having placed blind trust in physicians in

industry and government, who are promoting mass, mandatory use of

multiple vaccines, will be far higher in the future.